Results 161 to 170 of about 1,552,951 (302)

A luminal non‐coding RNA‐based genomic classifier confirms favourable outcomes in patients with clinically organ‐confined bladder cancer treated with radical cystectomy

BJU International, Volume 135, Issue 4, Page 648-656, April 2025.
Objective To further evaluate a genomic classifier (GC) in a cohort of patients undergoing radical cystectomy (RC), as long non‐coding RNA (lncRNA)‐based genomic profiling has suggested utility in identifying a distinct tumour subgroup corresponding to a favourable prognosis in patients with bladder cancer.
Joep J. de Jong, James A. Proudfoot, Siamak Daneshmand, Robert S. Svatek, Vikram Narayan, Ewan A. Gibb, Elai Davicioni, Shreyas Joshi, Aaron Dahmen, Roger Li, Brant A. Inman, Paras Shah, Iftach Chaplin, Jonathan Wright, Yair Lotan   +14 more
wiley   +1 more source

Invasive breast papillary carcinoma with mucinous stroma

Polish Journal of Pathology
Invasive breast papillary carcinoma is a rare type of breast cancer histologically characterized by infiltrative papillary growth without visible surrounding fibrous capsule.
Joško Bezić, Toni Čeprnja
doaj   +1 more source

Long‐term outcomes following a 5‐year recurrence‐free interval in non‐muscle‐invasive bladder cancer

BJU International, EarlyView.
Objective To describe the recurrence and progression trends of non‐muscle‐invasive bladder cancer (NMIBC) during a 14‐year period in Denmark between 2009 and 2022. Furthermore, to evaluate the risk of late recurrence with or without progression in patients who initially experience a 5‐year recurrence‐free interval (RFI).
Peter B. Hjort, Jørgen B. Jensen, Andreas Ernst   +2 more
wiley   +1 more source

Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma.

New England Journal of Medicine, 2016
W. Linehan, P. Spellman, C. Ricketts, C. Creighton, S. Fei, Caleb F. Davis, D. Wheeler, Bradley A. Murray, L. Schmidt, C. Vocke, Myron Peto, A. A. M. Al Mamun, E. Shinbrot, A. Sethi, S. Brooks, W. Rathmell, Angela N. Brooks, K. Hoadley, A. G. Robertson, Denise Brooks, R. Bowlby, S. Sadeghi, Hui Shen, D. Weisenberger, M. Bootwalla, S. Baylin, P. Laird, A. Cherniack, G. Saksena, S. Haake, Jun Li, Han Liang, Yiling Lu, G. Mills, Rehan Akbani, Mark D. M. Leiserson, Benjamin J. Raphael, Pavana Anur, D. Bottaro, L. Albiges, N. Barnabas, T. Choueiri, B. Czerniak, A. Godwin, A. Hakimi, T. Ho, J. Hsieh, M. Ittmann, William Y. Kim, B. Krishnan, M. Merino, K. R. Mills Shaw, V. Reuter, Ed Reznik, C. Shelley, B. Shuch, S. Signoretti, R. Srinivasan, P. Tamboli, G. Thomas, S. Tickoo, K. Burnett, D. Crain, J. Gardner, Kevin R Lau, D. Mallery, S. Morris, J. Paulauskis, R. Penny, C. Shelton, W. T. Shelton, M. Sherman, E. Thompson, P. Yena, Melissa Avedon, Jay Bowen, J. Gastier-Foster, M. Gerken, K. Leraas, T. Lichtenberg, N. Ramirez, T. Santos, L. Wise, E. Zmuda, J. Demchok, Ina Felau, C. Hutter, Margi Sheth, H. Sofia, R. Tarnuzzer, Zhining Wang, Liming Yang, J. Zenklusen, Jiashan Zhang, B. Ayala, J. Baboud, Sudha Chudamani, Jia Liu, Laxmi Lolla, R. Naresh, T. Pihl, Qiang Sun, Yunhu Wan, Ye Wu, Adrian Ally, M. Balasundaram, S. Balu, R. Beroukhim, T. Bodenheimer, C. Buhay, Y. Butterfield, R. Carlsen, S. Carter, H. Chao, E. Chuah, A. Clarke, K. Covington, M. Dahdouli, N. Dewal, Noreen Dhalla, H. Doddapaneni, J. Drummond, S. Gabriel, R. Gibbs, R. Guin, Walker Hale, A. Hawes, D. Hayes, R. Holt, A. Hoyle, S. Jefferys, Steven J. M. Jones, Corbin D. Jones, D. Kalra, C. Kovar, L. Lewis, Jie Li, Yussanne Ma, M. Marra, Michael Mayo, S. Meng, M. Meyerson, P. Mieczkowski, Richard A. Moore, Donna Morton, Lisle E. Mose, A. Mungall, D. Muzny, J. Parker, C. Perou, J. Roach, J. Schein, S. Schumacher, Yan Shi, J. Simons, Payal Sipahimalani, Tara J. Skelly, Matthew G. Soloway, C. Sougnez, Angela Tam, Donghui Tan, N. Thiessen, Umadevi Veluvolu, Min Wang, M. Wilkerson, Tina Wong, Junyuan Wu, Liu Xi, Jane H. Zhou, Jason Bedford, Fengju Chen, Yao Fu, M. Gerstein, D. Haussler, K. Kasaian, Phillip H. Lai, Shiyun Ling, Amie Radenbaugh, D. J. Van Den Berg, J. Weinstein, Jingchun Zhu, Monique Albert, I. Alexopoulou, Jeremiah J. Andersen, J. Auman, J. Bartlett, S. Bastacky, Julie Bergsten, M. Blute, L. Boice, R. Bollag, J. Boyd, E. Castle, Ying-bei Chen, J. Cheville, Erin E. Curley, B. Davies, April DeVolk, R. Dhir, Laura Dike, J. Eckman, J. Engel, Jodi Harr, R. Hrebinko, Meijuan Huang, L. Huelsenbeck-Dill, M. Iacocca, B. Jacobs, M. Lobis, J. Maranchie, S. McMeekin, J. Myers, J. Nelson, J. Parfitt, A. Parwani, N. Petrelli, B. Rabeno, Somak Roy, A. Salner, J. Slaton, M. Stanton, R. Thompson, L. Thorne, Kelinda Tucker, P. Weinberger, C. Winemiller, L. A. Zach, R. Zuna   +227 more
semanticscholar   +1 more source

Malignant craniopharyngiomas: Institutional experience and literature review

Brain Pathology, EarlyView.
We report the second case of malignant craniopharyngioma with BAP1 and TP53 mutations. A literature review identified 44 cases of malignant craniopharyngiomas with a median overall survival of 6 months. Eighteen (41%) occurred in patients without any history of radiation, suggesting that mechanisms other than radiation have contributed to their ...
Thomas J. Auen, Isabella W. Zhang, Weiwei Zhang, Jordan M. Burr, Matthew L. Carda, James L. Wisecarver, Nicole Shonka, Jesse L. Cox, Sahara J. Cathcart, Allison Cushman‐Vokoun, Jie Chen   +10 more
wiley   +1 more source

TNMplot: An enhanced platform for pharmacological target identification through cross‐stage and pan‐cancer gene expression analysis

British Journal of Pharmacology, EarlyView.
TNMplot.com, a web‐based platform integrating RNA‐Seq and gene‐chip data from 56,938 samples, enables differential gene expression analysis across normal, primary tumour and metastatic tissues, facilitating large‐scale transcriptomic profiling across 22 tumour types.
Áron Bartha, Balázs Győrffy
wiley   +1 more source

Pre‐RAI Monocyte‐to‐Lymphocyte Ratio Predicts Early and Higher Recurrence Risk in Intermediate‐Risk DTC, While PNI and NRI Show No Prognostic Value

Clinical Endocrinology, EarlyView.
ABSTRACT Objective Differentiated thyroid carcinoma (DTC) has an excellent prognosis, but recurrence remains a clinical concern, especially in intermediate‐risk patients. Current stratification systems focus primarily on tumor characteristics, overlooking the host's biological capacity to counteract tumor progression.
Tommaso Piticchio, Francesco Galeano, Salvatore Volpe, Antonio Prinzi, Ignazio Barca, Andrea Scuto, Rosario Le Moli, Giulio Geraci, Andrea Tumminia, Sium Wolde Sellasie, Francesco Pallotti, Francesco Frasca   +11 more
wiley   +1 more source

Molecular alterations of coexisting thyroid papillary carcinoma and anaplastic carcinoma: identification of TERT mutation as an independent risk factor for transformation

Modern Pathology, 2017
Naoki Oishi, T. Kondo, A. Ebina, Yukiko Sato, J. Akaishi, Rumi Hino, N. Yamamoto, Kunio Mochizuki, T. Nakazawa, H. Yokomichi, Koichi Ito, Y. Ishikawa, R. Katoh,   +12 more
semanticscholar   +1 more source

Solid papillary carcinoma with reverse polarity of the breast harbors specific morphologic, immunohistochemical and molecular profile in comparison with other benign or malignant papillary lesions of the breast: a comparative study of 9 additional cases

Modern Pathology, 2018
Nadjla Alsadoun, G. MacGrogan, C. Truntzer, M. Lacroix-Triki, I. Bedgedjian, M. Koeb, E. El Alam, D. Medioni, Michel Parent, P. Wuithier, I. Robert, R. Boidot, L. Arnould   +12 more
semanticscholar   +1 more source

Comparative Analysis of Incidental and Non‐Incidental Papillary Thyroid Microcarcinoma Outcomes: Implications on Management Recommendations

Clinical Endocrinology, EarlyView.
ABSTRACT Introduction Papillary thyroid microcarcinomas (PTMC) are defined by the World Health Organisation (WHO) as tumours measuring ≤ 10 mm. Incidental PTMCs, or lesions discovered postoperatively on histological examination, are less extensively studied compared with lesions diagnosed preoperatively through cytology, particularly in terms of ...
Emma A. Finnegan, Justin M. Hintze, Anne McGowan, James Gibney, Conall W. R. Fitzgerald, John Kinsella, Marie Louise Healy   +6 more
wiley   +1 more source